Senegal registers medicines through its regulator ARP and buys public-sector supply through PNA.

The regulator is ARP, and the name matters

Senegal's medicines are regulated by the Agence sénégalaise de Réglementation pharmaceutique (ARP), created by Décret n° 2022-824. ARP is an autonomous agency, not a department of the health ministry, and it now runs the country's product register, import authorisations, pharmacovigilance and inspections. Before 2022 this work sat inside a health-ministry pharmacy directorate; suppliers and consultants still citing that older structure as the current authority are working from an out-of-date reference.

ARP publishes its list of authorised medicines (AMM holders), its texts and decrees, and runs a portal for registration filings. For a foreign exporter this is the single body to track: registration status, import permits and establishment licensing for wholesalers and industry all sit under ARP now.

For the wider country picture, including logistics through Dakar and product categories in demand, see the M Care Exports Senegal market page.

AMM: registering a foreign medicine before it can be sold

No medicine, Indian-manufactured or otherwise, can be marketed in Senegal without a product-specific AMM issued by ARP. The dossier follows the same broad structure most French-speaking African regulators expect: administrative documents, quality (chemistry, manufacturing and controls), and clinical/safety data, submitted in French. ARP also publishes specific rules for categories such as herbal medicines, and separate texts for import authorisation requests once a product is on the register.

Two points matter for an Indian manufacturer or its export partner. First, the dossier has to be built and filed correctly the first time; regulators in this region reject submissions on format and completeness before they ever assess the science. Second, French is not optional, not for the dossier and not for the pack. M Care Exports prepares CTD-format dossiers and coordinates translation so the submission matches what ARP's reviewers actually expect to see.

Importing and wholesaling: a pharmacist has to be in the chain

Senegal's rules for opening and operating a pharmaceutical establishment, set out in Décret n° 2023-2421 (27 December 2023), require industrial and wholesale distribution establishments to designate a pharmacien responsable, a named, qualified pharmacist accountable for the establishment's operations. In practice this means the party importing and distributing product inside Senegal has to be a licensed pharmaceutical establishment with a responsible pharmacist named on file with ARP, not a general trading company.

For M Care Exports as an Indian merchant-exporter, that requirement sits on the Senegalese side of the transaction. M Care Exports supplies the product, the documentation and the compliance file; the Senegalese importer of record is the licensed, pharmacist-led establishment that holds the local authorisation to bring the shipment in and distribute it.

PNA: where public-sector and donor-funded demand sits

The SEN-Pharmacie Nationale d'Approvisionnement (SEN-PNA), still widely called the PNA, is the country's central public procurement and distribution body. It has recently changed status from a non-hospital public health establishment to a public industrial and commercial establishment (EPIC). It supplies essential medicines through a national network of regional stores down to health posts and health centres, and it runs major national health programmes, including malaria, HIV and family planning supply. PNA works with a qualified network of suppliers and maintains a relationship separate from ARP's regulatory function: ARP decides whether a product may be sold in Senegal at all, PNA decides who supplies the public sector once it is registered.

An AMM is the entry ticket; it does not by itself win PNA business. Suppliers still have to meet PNA's own qualification and quality-certification expectations and respond to its specific documentation requirements. Kenya and Ethiopia run comparable structures, where a national regulator and a separate central procurer both have to be satisfied; see how that plays out in Kenya's KEMSA/PPB model and Ethiopia's EFDA process.

Regional harmonisation and WHO prequalification: use with care

Senegal is a UEMOA member state, and West Africa has an active regional programme, the WA-MRH (harmonisation de la réglementation des médicaments en Afrique de l'Ouest), run through WAHO/OOAS, alongside the longer-term African Medicines Agency treaty process. None of this currently replaces ARP's national AMM: the operative registration route for a medicine entering Senegal is still the national dossier filed with ARP.

The same discipline applies to WHO prequalification. A WHO-Prequalified product can strengthen a dossier and may shorten review in regulators that have published a formal reliance policy, but ARP has not published fee, timeline or reliance detail specific enough to promise a faster route on that basis alone. The safer approach is to build the full national file and treat WHO-PQ status as supporting evidence, confirming any reliance provision directly with ARP at filing time. The general logic of national versus prequalification-based registration is covered in WHO prequalification vs national registration.

What has to come from the Indian side

An ARP-ready dossier needs a defined set of documents from the manufacturer and the exporter, gathered and formatted before filing rather than chased afterwards:

• Certificate of Pharmaceutical Product (CPP), issued by the Indian regulatory authority in the WHO format, confirming the product's market status in India
• Manufacturing site GMP certificate
• Free Sale Certificate for the specific product
• Full quality dossier: composition, manufacturing process, specifications, stability data
• Certificate of Analysis for the batch offered
• Product labelling and package insert, prepared in French for the Senegalese market, not translated after the fact
• Commercial documents: proforma invoice, packing list, and legalisation/apostille on the regulatory certificates as ARP requires

M Care Exports assembles this pack against the destination regulator's actual checklist rather than a generic template, because a dossier that reads as translated, rather than written for a French-speaking regulator, is one of the more common reasons filings stall. Buyers can start that conversation through Request a Medicine or set up ongoing sourcing through a trade account.

Frequently asked

What is Senegal's medicine regulator called now?

It is the Agence sénégalaise de Réglementation pharmaceutique, known as ARP, created by Décret n° 2022-824 in 2022. ARP is a standalone agency, not a directorate inside the health ministry, and it now handles product registration (AMM), import authorisation, pharmacovigilance and establishment licensing. If a supplier or consultant refers to an older pharmacy directorate as the current authority, that reference is out of date; ARP is the body to deal with for any registration or import question in Senegal today.

Can an Indian manufacturer register a product in Senegal directly?

The AMM dossier is filed with ARP and the product goes on Senegal's national register, but the establishments permitted to import and distribute inside the country are licensed local entities with a designated responsible pharmacist, under Décret n° 2023-2421. In practice, an Indian manufacturer or exporter builds and supplies the regulatory dossier, and a licensed Senegalese pharmaceutical establishment is the importer of record. M Care Exports coordinates the dossier and documentation on the Indian side of that arrangement.

Does M Care Exports supply PNA tenders in Senegal?

M Care Exports supplies documentation and product to the licensed importers and distributors who engage with SEN-PNA, the Pharmacie Nationale d'Approvisionnement (formerly PNA), on tenders and public-programme procurement. PNA sets its own supplier qualification and documentation requirements separately from ARP's registration process, so a product needs a valid AMM first and then has to meet PNA's specific requirements before it can be offered into public-sector or donor-funded supply.

Is WHO prequalification enough to register a medicine in Senegal?

Not on its own. ARP runs a national registration process, and WHO-Prequalified status is useful supporting evidence within a dossier rather than a confirmed fast-track. Regional harmonisation efforts across West Africa, including the WA-MRH programme run by WAHO/OOAS, are active but have not replaced the national AMM route. The reliable approach is to prepare a full national dossier and check current reliance provisions with ARP directly at the time of filing, since these details can change.

Are Senegal's registration dossiers and product labels really required in French?

Yes. Senegal is a French-speaking market and ARP reviews dossiers, correspondence and product information in French. Labelling and package inserts for the Senegalese market need to be written in French, not machine-translated from an English source pack. This is one of the more common points where filings from suppliers unfamiliar with the market lose time, and it is why M Care Exports prepares French-language documentation as part of the dossier build rather than as an afterthought.

What documents does M Care Exports provide for a Senegal registration file?

The core pack includes a Certificate of Pharmaceutical Product in WHO format, the manufacturing site's GMP certificate, a Free Sale Certificate, the full quality dossier (composition, process, specifications, stability), a batch Certificate of Analysis, French-language labelling and package inserts, and the standard commercial documents with legalisation where ARP requires it. M Care Exports assembles this against ARP's actual current checklist rather than a generic export template.